HYPR Hyperfine, Inc.
Data as of close
Healthcare · Electromedical & Electrotherapeutic Apparatus
Hyperfine, Inc. (HYPR) is a healthcare company in the Electromedical & Electrotherapeutic Apparatus industry, with a market capitalization of $74 million. Shares last traded at $0.75, 61.4% below their 52-week high. Over the past year the stock is down 33.3%. Net profit margin is -210.8%, below the peer median of -10.0%. Revenue grew 5.2% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | -$0.09 | 2026-08-06 |
| Q1 2026 | -$0.09 | 2026-05-12 |
| Q4 2025 (derived) | -$0.05 | 2026-03-18 |
| FY 2025 | -$0.43 | 2026-03-18 |
| Q3 2025 | -$0.14 | 2025-11-13 |
| Q2 2025 | -$0.12 | 2025-08-13 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Electromedical & Electrotherapeutic Apparatus peers
HYPR vs 14 industry peers (Electromedical & Electrotherapeutic Apparatus), by market cap. Data as of close
| MDT | Medtronic | $134.4B | 25.69 | 3.58 | 13.9% | +6.22% |
| LIVN | Livanova Plc | $5.2B | 26.47 | 3.44 | 13.0% | +17.67% |
| ITGR | Integer Holdings Corp | $4.3B | 41.52 | 2.36 | 5.7% | +0.02% |
| AXGN | Axogen, Inc. | $3.1B | — | 11.49 | -12.0% | +3.67% |
| TMDX | Transmedics Group, Inc. | $2.5B | 16.62 | 3.77 | 22.7% | +7.85% |
| CNMD | Conmed Corp | $1.6B | 34.01 | 1.16 | 3.4% | +13.41% |
| CBLL | Ceribell, Inc. | $1.1B | — | 9.76 | -68.0% | -3.50% |
| INMD | Inmode Ltd. | $899M | 9.58 | 2.43 | 25.3% | +0.67% |
| CV | CapsoVision, Inc | $345M | — | — | — | +2.91% |
| ELMD | Electromed, Inc. | $234M | 20.70 | 3.17 | 15.3% | +4.25% |
| FOCL | EDAP TMS SA | $161M | — | 2.28 | -41.5% | -0.46% |
| VANI | Vivani Medical, Inc. | $97M | — | — | — | +1.42% |
| STXS | Stereotaxis, Inc. | $96M | — | 3.18 | -74.2% | +12.13% |
| NRXS | Neuraxis, INC | $86M | — | — | — | +2.94% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.